Conference Coverage
Conference Coverage
Twenty years and counting: Tamoxifen’s lasting improvement in breast cancer
Study suggests long-term improvement for some women with breast cancer.
Conference Coverage
Uninformed breast cancer patients are making treatment decisions
Clouded by the thought “I have breast cancer,” patients are making uninformed treatment decisions.
Conference Coverage
Telehealth continues to loom large, say experts
Nine out of ten patients would recommend telemedicine to friends and family, and most physicians say they’re willing to devote significant time to...
Conference Coverage
Novartis suspends two cancer therapies over quality concerns
“Novartis is conducting a thorough review of the situation and currently expects to resolve the issues and resume some supply in the next six...
Conference Coverage
Misconceptions remain on gene signature use in breast cancer
The “misconception regarding the predictive value of these tests on chemotherapy benefits suggest there is still room for training on results...
News
Noninvasive esophageal cancer screening approaches may reach more at-risk patients
Noninvasive approaches have lower sensitivity and specificity than endoscopic screening, but greater access could make them cost effective.
Conference Coverage
Which solid organ transplant recipients face the highest risk of skin cancer?
Those at low risk for skin cancer include abdominal organ recipients, SOTR age of younger than 50 at time of transplant, and female gender.
Conference Coverage
Preop nivolumab plus chemo ‘a quantum leap’ in NSCLC therapy
The combination resulted in significantly longer event-free survival.
Conference Coverage
Made-to-order TILs effective against metastatic melanoma
The product, called lifileucel, is custom made for each patient.
Conference Coverage
Program successfully boosts pediatric cancer research
In the year prior to RACE implementation, there were no approvals of therapeutics.
Conference Coverage
Recurrent DCIS can be genetically distinct from primary lesion
Findings may change how breast cancer patients are treated.